# Edgewise Therapeutics, Inc. — Form D

Edgewise Therapeutics, Inc. of Boulder, CO, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-10. The offering totals $95.0M, of which $95.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-12-10
- Form: D
- Accession: 0001710072-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $95.0M
- Amount sold: $95.0M
- Investors: 21
- Date of first sale: 2020-12-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-382855

## Issuer

- Name: Edgewise Therapeutics, Inc.
- CIK: 0001710072
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 3415 Colorado Ave, Boulder, CO, 80303
- Phone: (303) 735-8373

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Kenneth Harrison | Director | Half Moon Bay, CA |
| KEVIN KOCH | Director | WOBURN, MA |
| Jonathan Root | Director | Aliso Viejo, CA |
| Alan Russell | Director | Boulder, CO |
| Peter Thompson | Director | Chanhassen, MN |
| KEVIN KOCH | Executive Officer | WOBURN, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-09-26](https://search.stillhousedata.com/formd/0001710072-19-000001) | D | $50.1M | $25.1M |

## More

- [CIK 1710072 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1710072&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001710072-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.